Prostatectomy vs Radiotherapy for Prostate Cancer

Prostatectomy removes the prostate, while radiotherapy treats cancer cells with targeted radiation; the choice depends on tumour features, health, and personal priorities.

A surgical approach may be discussed when the cancer is suitable for removal and the person can reasonably undergo an operation. Some people prefer removal of the prostate and clear examination of the tissue after surgery. That examination can help the team understand the tumour more precisely and decide whether further care is needed. Recovery time, anaesthesia, urinary leakage, and possible effects on erections should be part of the decision, not an afterthought.

Radiotherapy may suit someone seeking treatment without prostate removal, or someone for whom surgery carries additional concern. Planning uses scans and treatment positioning to direct radiation to the intended area. Depending on the plan, medicines that lower male hormones may be added. The team will review urinary symptoms, bowel health, previous procedures, sexual function, and the practical demands of attending treatment visits.

Both choices can affect daily life, but their timing and pattern differ. Surgery can cause pain, fatigue, bleeding, infection, urinary leakage, or erection difficulties during recovery. Radiotherapy can irritate the bladder or bowel, causing changes such as urgency, frequency, loose stools, or discomfort; tiredness may build during treatment. Hormone medicines, when used, can cause hot flushes, lower libido, mood changes, and loss of muscle strength. Ask which effects are temporary, which may last, and what support is available.

Neither option is automatically right for every person. Active surveillance may be discussed for selected cancers that appear unlikely to cause immediate harm, with scheduled tests and reviews. Hormone treatment, chemotherapy, or a combined approach may be considered when cancer has features that make local treatment alone unsuitable. The team may also recommend symptom-focused care when treatment burdens outweigh likely benefit. A second specialist opinion can help when the options remain closely balanced.

The clinical team brings together biopsy findings, PSA pattern, scans, tumour grade, prostate size, overall health, medicines, and expected lifespan. They also consider urinary and bowel symptoms, sexual function, previous pelvic treatment, practical access to visits, and what matters most to you. Ask for the cancer stage and grade in plain language, the goal of treatment, alternatives, likely short-term effects, possible long-term effects, and how recurrence would be monitored. Taking time to compare a personalised plan with a second opinion is reasonable.